Strong track record in industry

The interdisciplinary LDC team merges top scientific expertise in drug discovery with solid and professional project management know-how gained by LDC scientists and managers during many years in the biotechnology and pharmaceutical industries.

Managing Directors

  • Bert Klebl, PhD Managing Director and Chief Scientific Officer
  • Peter Nussbaumer, PhD Managing Director and Head of Medicinal Chemistry

Department Heads

  • Johannes Bange, PhD Therapeutic Antibodies
  • Matthias Baumann, PhD Head of Pharmacology
  • Axel Choidas, PhD Head of Biology
  • Jan Eickhoff, PhD Head of Assay Development & Screening
  • Michael Hamacher, PhD Head of Finance & Business Development


Bert Klebl has gathered more than twelve years of professional experience in the life sciences industry. He has worked in different positions in drug discovery and early development, most recently as Senior Director Discovery Biology and Head of Biology at GPC Biotech. Previously he was Axxima’s Vice President Research and as such responsible for the discovery and development of the company’s portfolio of kinase inhibitors for various therapeutic indications. In former positions, he has worked as a project and platform manager, as well as a scientist at Aventis and Hoechst Marion Roussel.

He earned his PhD in biochemistry at the University of Konstanz, Germany, and did postdoctoral work at the NRC Biotechnology Research Institute in Montréal, Canada. In the course of his research, he has published more than 30 articles in peer-reviewed journals and is a co-inventor of more than 20 patents and patent applications.

Dr. Bert Klebl

Bert Klebl, PhD Managing Director

Peter Nussbaumer brings more than 20 years of industry experience from drug discovery and early drug development to the team. Before joining the LDC, he held various positions in the area of medicinal chemistry, most recently as Executive Director and Senior Unit Head of Chemistry at the Novartis Institutes for Biomedical Research in Vienna. He also managed a broad range of drug discovery projects and gained extensive experience in coordinating interdisciplinary and international project teams.

He holds a PhD in organic chemistry from the Vienna University of Technology, has published 60 articles in peer-reviewed journals and is co-inventor of more than 20 patents and patent applications.

Dr. Peter Nussbaumer

Peter Nussbaumer, PhD Managing Director